Back to search
FDAFDA · Food and drugs·Recall number D-0168-2027

DELFLEX Peritoneal Dialysis Solution with 2.5% Dextrose, Low Magnesium/ Low Calcium and Attached stay safe Exchange Set, 2,000 mL Single dose bag, Sterile and Non-Pyrogenic, Rx only, CAT. No. 054-20222. Fresenius Medical Care, Renal Therapies Group, LLC, Lawrence, MA 01843. NDC 46163-209-92

Published November 11, 2026 · Recall initiated: October 14, 2026

Summary

FDA records drug Class II recall D-0168-2027, published November 11, 2026 and initiated October 14, 2026. Recalling firm: Fresenius Medical Care Renal Therapies Group, LLC; Status: Ongoing; Reported quantity: 6,283 cases (5 bags per case); Lot: Lot # 25DGPD002, 25DGPD003, Exp 10/31/2026; 25KGPD027, 25KGPD042, Exp 2/28/2027; 25SGPD033, Exp 6/30/2027; 26AGPD033, 26AGPD054, Exp 7/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.

What to do

Voluntary: Firm initiated · Letter

Get an email if DELFLEX has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DELFLEX
Manufacturer
Fresenius Medical Care Renal Therapies Group, LLC
Distributor
Nationwide in the USA.
Lot
Lot # 25DGPD002, 25DGPD003, Exp 10/31/2026; 25KGPD027, 25KGPD042, Exp 2/28/2027; 25SGPD033, Exp 6/30/2027; 26AGPD033, 26AGPD054, Exp 7/31/2027.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was DELFLEX Peritoneal Dialysis Solution with 2.5% Dextrose, Low Magnesium/ Low Calcium and Attached stay safe Exchange Set, 2,000 mL Single dose bag, Sterile and Non-Pyrogenic, Rx only, CAT. No. 054-20222. Fresenius Medical Care, Renal Therapies Group, LLC, Lawrence, MA 01843. NDC 46163-209-92 recalled?

Yes. FDA published recall D-0168-2027 on November 11, 2026. Reported hazard: Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DELFLEX.